RYTM
Rhythm Pharmaceuticals, Inc. · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers):
breedte van houders +16.7% ·
aandelenstroom +1.0% ·
netto nieuwe posities +14.3%
— formule
Brede accumulatie — stijgende aandelen bij meer houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q1 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 113 | +6 | 44.38M | $4.90B | +14 | −7 |
| Q1 2026 | 109 | +6 | 41.83M | $3.64B | +11 | −6 |
| Q4 2025 | 102 | 0 | 43.14M | $4.62B | +3 | −2 |
| Q3 2025 | 20 | +1 | 28.88M | $2.92B | +2 | −2 |
| Q2 2025 | 17 | 0 | 22.96M | $1.45B | +1 | −1 |
| Q1 2025 | 14 | +2 | 11.52M | $610.22M | +2 | — |
| Q4 2024 | 12 | 0 | 11.40M | $638.39M | — | — |
| Q3 2024 | 11 | +3 | 9.71M | $508.75M | +3 | — |
| Q2 2024 | 8 | — | 9.56M | $392.54M | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | PRIMECAP Management ✦ | 5.79M | -11.9% | $306.55M | 0.3% | ▼ Trim | 4 | SEC ↗ |
| 2 | State Street Global Advisors ✦ (passief) | 1.97M | +7.0% | $104.39M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passief) | 1.29M | +2.5% | $68.20M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passief) | 1.29M | +2.5% | $68.20M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 5 | T. Rowe Price ✦ | 1.20M | +75.0% | $63.52M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 6 | T. Rowe Price ✦ | 1.20M | +75.0% | $63.52M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 7 | Marshall Wace ✦ | 535.10K | -22.8% | $28.34M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 8 | Marshall Wace ✦ | 535.10K | -22.8% | $28.34M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 9 | Norges Bank ✦ (passief) | 223.48K | +8.7% | $11.84M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 10 | Millennium Management ✦ | 217.38K | +1324.6% | $11.51M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 11 | D. E. Shaw & Co. ✦ | 83.87K | +74.0% | $4.44M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 12 | D. E. Shaw & Co. ✦ | 83.87K | +74.0% | $4.44M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 13 | Citadel Advisors ✦ | 70.07K | +73.3% | $3.71M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 14 | Citadel Advisors ✦ | 70.07K | +73.3% | $3.71M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 15 | Point72 Asset Management ✦ | 63.84K | Nieuw | $3.38M | 0.0% | New | 1 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 39.36K | +148.2% | $2.09M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 39.36K | +148.2% | $2.09M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 39.36K | +148.2% | $2.09M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 19 | AQR Capital Management ✦ | 39.36K | +148.2% | $2.09M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 20 | AQR Capital Management ✦ | 39.36K | +148.2% | $2.09M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 21 | Wellington Management ✦ | 23.56K | -7.8% | $1.25M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 22 | Wellington Management ✦ | 23.56K | -7.8% | $1.25M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 23 | Wellington Management ✦ | 23.56K | -7.8% | $1.25M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 24 | Wellington Management ✦ | 23.56K | -7.8% | $1.25M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 25 | Renaissance Technologies ✦ | 14.11K | Nieuw | $747,513 | 0.0% | New | 1 | SEC ↗ |
| 26 | Gotham Asset Management ✦ | 4.75K | -30.0% | $251,608 | 0.0% | ▼ Trim | 4 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Point72 Asset Management | $3.38M | 0.0% |
| Renaissance Technologies | $747,513 | 0.0% |
Verlaten
| Geen bijgehouden uitstappen dit kwartaal. |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 284 houders, 72.02M aandelen, $6.12B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Officer · 2.01K aand · $233,031
Officer · 1.56K aand · $182,170
Officer · 3.40K aand · $402,167
Officer · 800 aand · $95,335
Officer · 75.83K aand · $8.90M
Officer · 2.30K aand · $257,138
Officer · 1.00K aand · $112,856
Officer · 3.60K aand · $413,477
Officer · 14.57K aand · $1.68M
Officer · 18.21K aand · $2.12M
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie